Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-460P (RNA, U6 small nuclear 460, pseudogene) is a genomic sequence derived from the U6 snRNA gene family, classified as a pseudogene. The U6 snRNA gene encodes a highly conserved small nuclear RNA component essential for the spliceosome, a complex responsible for mediating pre-mRNA splicing in eukaryotic nuclei[5][4]. Pseudogenes like RNU6-460P result from duplication or retrotransposition events involving functional U6 snRNA genes, but they typically lack regulatory sequences or functional coding capacity, rendering them biologically inert in terms of transcription or participation in molecular pathways[1]. RNU6-460P is annotated in genomic databases as a pseudogene, without known involvement in cellular signaling, disease processes, or drug interactions. If you require structured information about functional U6 snRNA, see: - canonical_name: U6 small nuclear RNA - molecular_classification: Small nuclear RNA (snRNA), component of spliceosome - biological_functions: mRNA splicing, spliceosome assembly and catalysis[5][4]. - disease_roles: Indirectly, defects in snRNA processing can contribute to splicing disorders, though no known direct role for RNU6-460P pseudogene. Note: RNU6-460P should not be considered a primary molecular target for drug discovery, diagnostics, or therapeutic intervention. For spliceosome function, refer to active U6 small nuclear RNA.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 460, pseudogene (RNU6-460P).